Wuhan Dazhong Dental Reports 9.2% Revenue Decline for H1 2025, Cost of Sales Down 10.9%

Reuters

Aug 29

Wuhan Dazhong Dental Reports 9.2% Revenue Decline for H1 2025, Cost of Sales Down 10.9%

Wuhan Dazhong Dental Medical Co. Ltd. announced its unaudited consolidated financial results for the six months ended 30 June 2025. The company reported a 9.2% decrease in revenue, amounting to RMB185.8 million compared to RMB204.5 million in the same period in 2024. This decline was primarily attributed to a reduction in revenue across all business lines, with general dentistry services decreasing by 7.9% to RMB102.0 million, implantology services dropping by 10.5% to RMB53.6 million, and orthodontics services falling by 10.9% to RMB30.2 million. The cost of sales also saw a decrease of 10.9%, down from RMB129.7 million for the first half of 2024 to RMB115.5 million for the corresponding period in 2025. The reduction in costs was mainly due to lower expenses in consumables and customized products, staff costs, and depreciation and amortization. The company did not provide any specific outlook or guidance for future periods within this announcement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuhan Dazhong Dental Medical Co. Ltd. published the original content used to generate this news brief on August 29, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2563029609"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2563029609\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2563029609?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-29 21:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2563029609","market":"nz","top_or_hot":-1,"title":"Wuhan Dazhong Dental Reports 9.2% Revenue Decline for H1 2025, Cost of Sales Down 10.9%","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Wuhan Dazhong Dental Reports 9.2% Revenue Decline for H1 2025, Cost of Sales Down 10.9%\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Wuhan Dazhong Dental Medical Co. Ltd. announced its unaudited consolidated financial results for the six months ended 30 June 2025. The company reported a 9.2% decrease in revenue, amounting to RMB185.8 million compared to RMB204.5 million in the same period in 2024. This decline was primarily attributed to a reduction in revenue across all business lines, with general dentistry services decreasing by 7.9% to RMB102.0 million, implantology services dropping by 10.5% to RMB53.6 million, and orthodontics services falling by 10.9% to RMB30.2 million. The cost of sales also saw a decrease of 10.9%, down from RMB129.7 million for the first half of 2024 to RMB115.5 million for the corresponding period in 2025. The reduction in costs was mainly due to lower expenses in consumables and customized products, staff costs, and depreciation and amortization. The company did not provide any specific outlook or guidance for future periods within this announcement.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuhan Dazhong Dental Medical Co. Ltd. published the original content used to generate this news brief on August 29, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wuhan Dazhong Dental Reports 9.2% Revenue Decline for H1 2025, Cost of Sales Down 10.9%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWuhan Dazhong Dental Reports 9.2% Revenue Decline for H1 2025, Cost of Sales Down 10.9%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-29 21:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Wuhan Dazhong Dental Reports 9.2% Revenue Decline for H1 2025, Cost of Sales Down 10.9%\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Wuhan Dazhong Dental Medical Co. Ltd. announced its unaudited consolidated financial results for the six months ended 30 June 2025. The company reported a 9.2% decrease in revenue, amounting to RMB185.8 million compared to RMB204.5 million in the same period in 2024. This decline was primarily attributed to a reduction in revenue across all business lines, with general dentistry services decreasing by 7.9% to RMB102.0 million, implantology services dropping by 10.5% to RMB53.6 million, and orthodontics services falling by 10.9% to RMB30.2 million. The cost of sales also saw a decrease of 10.9%, down from RMB129.7 million for the first half of 2024 to RMB115.5 million for the corresponding period in 2025. The reduction in costs was mainly due to lower expenses in consumables and customized products, staff costs, and depreciation and amortization. The company did not provide any specific outlook or guidance for future periods within this announcement.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuhan Dazhong Dental Medical Co. Ltd. published the original content used to generate this news brief on August 29, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02651","symbol_name":"大众口腔","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nNDL2nPnjt:1","article_id":"2563029609","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2563029609","pubTimestamp":1756474561,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Wuhan Dazhong Dental Medical Co. Ltd. announced its unaudited consolidated financial results for the six months ended 30 June 2025. The company reported a 9.2% decrease in revenue, amounting to RMB185.8 million compared to RMB204.5 million in the same period in 2024. This decline was primarily attributed to a reduction in revenue across all business lines, with general dentistry services decreasing by 7.9% to RMB102.0 million, implantology services dropping by 10.5% to RMB53.6 million, and orthodontics services falling by 10.9% to RMB30.2 million. The cost of sales also saw a decrease of 10.9%, down from RMB129.7 million for the first half of 2024 to RMB115.5 million for the corresponding period in 2025. The reduction in costs was mainly due to lower expenses in consumables and customized products, staff costs, and depreciation and amortization. The company did not provide any specific outlook or guidance for future periods within this announcement.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"02651":"大众口腔"},"translate_title":"武汉大众口腔报告2025年上半年收入下降9.2%，销售成本下降10.9%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02651":0.9},"content_text":"Wuhan Dazhong Dental Reports 9.2% Revenue Decline for H1 2025, Cost of Sales Down 10.9%\n    \n\n        Wuhan Dazhong Dental Medical Co. Ltd. announced its unaudited consolidated financial results for the six months ended 30 June 2025. The company reported a 9.2% decrease in revenue, amounting to RMB185.8 million compared to RMB204.5 million in the same period in 2024. This decline was primarily attributed to a reduction in revenue across all business lines, with general dentistry services decreasing by 7.9% to RMB102.0 million, implantology services dropping by 10.5% to RMB53.6 million, and orthodontics services falling by 10.9% to RMB30.2 million. The cost of sales also saw a decrease of 10.9%, down from RMB129.7 million for the first half of 2024 to RMB115.5 million for the corresponding period in 2025. The reduction in costs was mainly due to lower expenses in consumables and customized products, staff costs, and depreciation and amortization. The company did not provide any specific outlook or guidance for future periods within this announcement.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuhan Dazhong Dental Medical Co. Ltd. published the original content used to generate this news brief on August 29, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}